RecruitingRecruiting
Activation Sarcoma: PROMIS and Mobility Evaluation in Sarcoma Patients
NCT07227961 · University of Calgary
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
Patient-Reported Outcomes and Smartphone-Derived Mobility After Bone and Soft Tissue Sarcoma Surgery: A Multicentre Prospective Cohort Study
About this study
Background \& Rationale:
Sarcoma is a rare form of bone and soft tissue cancer, making up about 1% of all adult cancers. Management typically involves radiation therapy, chemotherapy, and surgical resection, with or without limb reconstruction. The diagnosis, intensive treatment regimen, and surgery-induced deficits significantly impact patient quality of life and function.
Surgery is central to the treatment of bone and soft tissue sarcoma, yet postoperative recovery is difficult to measure because of disease rarity, heterogeneity, and treatment variation. Legacy instruments such as the Toronto Extremity Salvage Score (TESS) have ceiling effects, limited health-domain coverage, and response burden. The Patient-Reported Outcomes Measurement Information System (PROMIS) uses short surveys across multiple health domains that may better capture recovery. PROMIS was developed with oncology research considerations and has been validated in both orthopaedic and oncology populations. However, the significance of PROMIS in orthopaedic oncology is not well understood.
Assessing patient reported outcomes is limited by survey completion rates, particularly in the oncology patients who have multiple medical appointments and care teams. To address these challenges, our team has developed Activation Health, a smartphone application (app) tailored to musculoskeletal oncology. Unlike general fitness or commercial health applications, Activation Health remotely administers patient reported outcome measures (PROMs) and passively captures mobility metrics. The continuous data collection aligns real-world mobility with clinical recovery timelines, offering a more precise view of patient outcomes.
The overall aim of the study is to validate the PROMIS as an outcome measure in the sarcoma population, and to evaluate the Activation Health app for remote PROM administration and mobility data collection.
Hypothesis:
PROMIS and mobility metrics will provide a holistic and granular view of recovery trajectories, and the use of a novel smartphone application will improve patient engagement and data collection.
Specific Aims:
1. Compare the responsiveness of five PROMIS short forms to the TESS for assessing recovery after sarcoma surgery
2. Determine the minimal clinically important differences (MCID) for five PROMIS short forms in the sarcoma population
3. Assess the feasibility and usability of Activation Health for remote PROM survey administration and mobility data collection in the sarcoma population
4. Correlate PROM scores with mobility metrics to define recovery trajectories after sarcoma surgery
5. Identify demographic and socioeconomic factors that influence survey responses and engagement with the Activation Health app in the sarcoma population
Methods:
Recruitment and Sample Size:
This is a prospective, multicentre longitudinal cohort study involving the University of Calgary, University of Toronto, Mayo Clinic Rochester and Mayo Clinic Arizona. All eligible patients will be seen by a musculoskeletal oncology surgeons at one of the participating sites. Adult patients (≥18 years) diagnosed with an operative bone or soft tissue sarcoma are eligible for inclusion. Tumors can be primary or recurrent, and can be located in the upper extremities, pelvis, or lower extremities. Participants must speak English to be included in the study. The investigators anticipate enrolling approximately 800 sarcoma patients based on current surgical volumes and patient capture rates for collecting quality of life and functional data.
Data Collection:
Clinical data will be collected by an approved member of the research team using the local electronic medical record and a standardized case repot form. Participants will download the Activation Health app on their smartphone. A demographics survey, TESS, and PROMIS physical function, upper extremity, pain interference, global health, and self efficacy surveys will be administered remotely through the Activation Health app and Qualtrics. Completion of these surveys will be prompted via push notifications preoperative and at 6 weeks, 12 weeks, 6 months 12 months, 16 months, 20 months, and 24 months postoperative. Mobility metrics will be passively collected by the app throughout study involvement. The mobility metrics of interest include but are not limited to step count, distance travelled, move time, flights of stairs climbed, walking steadiness, walking asymmetry, double support time, walking speed, and step length. Additionally, physiological parameters such as maximum oxygen consumption (VO2 max) will be collected from participants with a compatible smartwatch. At the end of study participation, an additional surveys will be administered assess participant phone use habits and app function.
To improve study accessibility, participants without a compatible smartphone or unwilling to use the Activation Health app can contribute survey data using Qualtrics. The secure Qualtrics survey links will be distributed via email or text message (patient preference) by an approved member of the study team at pre-specified data collection timepoints. In addition, participants may contribute their mobility data at the end of study involvement during an in-person visit. For apple device users, secure data transfer can be facilitated via the AirDrop feature and for Android users via Google Takeout.
Statistical Analysis:
Summary statistics will describe population demographic and clinical characteristics. Continuous data will be represented as means with standard deviation or medians with interquartile range, and categorical data as proportions. Individual-level socioeconomic status will be calculated using household income, education level, and occupation.
The sensitivity of the PROMIS physical function and upper extremity function domains will be independently compared to the TESS using effect size and standardized response means. These measures will allow for comparison of whether the T-scores scores changed by a small or large amount over time. Additionally, the aggregate score of all the PROMIS domains will be compared to TESS. Aggregate scores will be calculated by averaging the five domain-specific T-scores. MCIDs for PROMIS domains will be calculated using an anchor-based method with the Global Rating of Change. The sensitivity of PROMIS will be compared to TESS using correlation coefficients, Bland-Altman plots, and linear regression models.
Mobility data will undergo principal component analysis to derive a composite index capturing the key features of interest. Ordinal logistic regression will be used to determine if mobility metrics collected form a smartphone are associated with patient-reported activity level, as assessed by a seven-point PGIC anchor question. Linear mixed-effects regression models will assess whether mobility changes are associated with changes in PROMIS and TESS scores.
The proportion of PROMIS and TESS questionnaires that are completed will be calculated. Logistic regression will be used to identify demographic factors that predict survey completion, with survey completion represented as a binary variable (yes or no).
Eligibility criteria
Inclusion Criteria:
* Age ≥ 18 years
* Diagnosis of bone sarcoma, soft tissue sarcoma, or giant cell tumor of bone
* Tumors located in the pelvis, lower extremities, or upper extremities
* Primary or recurrent disease
* Undergoing operative tumor resection, including limb salvage surgery and amputation
* Has an iPhone or Android smartphone
* Speaks English
Exclusion Criteria:
* Metastatic bone tumor
* Diagnosis of atypical lipomatous tumor
* Diagnosis of dermatofibrosarcoma protuberans
* Currently pregnant or planning pregnancy within 6 months
* Unwilling or unable to attend follow-up evaluations
* Cognitive or communication barriers that impede completion of questionnaires
Study design
Enrollment target: 800 participants
Age groups: adult, older_adult
Timeline
Starts: 2025-07-01
Estimated completion: 2031-01-01
Last updated: 2026-11-02
Interventions
Procedure: Surgery
Primary outcomes
- • Step count (From enrolment to two years postoperative)
- • Distance travelled (From enrolment two years postoperative)
- • Move time (From enrolment two years postoperative)
Sponsor
University of Calgary · other
With: University of Toronto, Mayo Clinic
All locations (4)
Mayo ClinicNot Yet Recruiting
Phoenix, Arizona, United States
Mayo ClinicNot Yet Recruiting
Rochester, Minnesota, United States
Foothills Medical Centre, Arthur J Child Comprehensive Cancer Centre, University of CalgaryRecruiting
Calgary, Alberta, Canada
Mount Sinai Hospital, University of TorontoRecruiting
Toronto, Ontario, Canada